Rights and permissions
About this article
Cite this article
Intracoronary streptokinase is cost-effective in patients with anterior myocardial infarction. Inpharma Wkly. 644, 3–4 (1988). https://doi.org/10.1007/BF03308542
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03308542